Skip to content
Zero Point Five Therapeutics, Inc.
  • Mission
  • Focus Areas
  • Pipeline
  • Designations
  • About
  • Contact
Learn More
← Back to home

Terms of Use

Last updated: 2026-04-21

Placeholder — this page contains template language and has not been reviewed by counsel. Replace before launch.

Acceptance

By accessing zeropointfivetherapeutics.com, you agree to be bound by these terms. If you do not agree, please do not use the site.

Informational use only

The content on this site is provided for general informational purposes only. It is not intended as medical advice, an offer to sell or solicitation to buy securities, or a recommendation regarding any specific therapeutic course of action. Always seek the advice of a qualified healthcare professional with any medical questions.

Forward-looking statements

This site contains forward-looking statements regarding clinical development, regulatory strategy, and potential commercialization of ZP5 product candidates. These statements involve risks and uncertainties that could cause actual results to differ materially from those projected.

Intellectual property

All content on this site, including text, graphics, logos, and design, is the property of Zero Point Five Therapeutics, Inc. or its licensors and is protected by applicable intellectual property laws. You may not reproduce or distribute material from this site without permission.

No warranty

The site is provided "as is" without warranties of any kind, express or implied.

Governing law

These terms are governed by the laws of the United States and the State of Maryland, without regard to conflict-of-laws principles.

Contact

Questions about these terms can be sent to contact@zeropointfivetherapeutics.com.

Zero Point Five Therapeutics, Inc.

Developing safe and efficacious treatments for neglected diseases.

Company
MissionFocus AreasPipelineDesignationsContact
Regulatory
Rare Pediatric Disease DesignationOrphan Drug DesignationClinicalTrials.gov
Contact
contact@zeropointfivetherapeutics.comzeropointfivetherapeutics.com
Forward-Looking Statements

This website contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the clinical development, regulatory strategy, and potential commercialization of Zero Point Five Therapeutics, Inc.'s product candidates. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including risks related to clinical trial outcomes, regulatory review and approval, manufacturing, competition, and market conditions. Forward-looking statements speak only as of the date on which they are made, and Zero Point Five Therapeutics, Inc. undertakes no obligation to update or revise any forward-looking statement, except as required by law.

Regulatory & Clinical Disclaimer

Zero Point Five Therapeutics, Inc.'s lead product candidate is an investigational drug that has not been approved by the U.S. Food and Drug Administration (FDA) or any other regulatory authority for any indication. The safety and efficacy of this investigational compound have not been established. Rare Pediatric Disease Designation and Orphan Drug Designation are granted by the FDA and are not a guarantee of regulatory approval. These designations provide certain development incentives but do not confirm that the product candidate will receive marketing approval or be commercially successful. Information on this website is intended for informational purposes only and does not constitute medical advice, a solicitation for investment, or an offer to sell securities.

No Offer of Securities

Nothing on this website constitutes an offer to sell, or a solicitation of an offer to buy, any securities of Zero Point Five Therapeutics, Inc. Any offering of securities will be made only pursuant to a formal offering memorandum or other applicable disclosure document in compliance with applicable federal and state securities laws.

© 2026 Zero Point Five Therapeutics, Inc. · All Rights Reserved
Privacy Policy·Terms of Use·Cookie Policy